Now Available:
Watch video podcasts of the 2008 EULAR press conferences

CME Opportunity:

Arthritis: Are More Vioxx-Like Drug Catastrophes Inevitable?
Sociologist predicts growing numbers of drug safety disasters because of fatal flaws in the way new drugs are tested and marketed...

Arthritis: OA Increase Among Women Seems Due to Obesity As Well As Aging
OA is becoming more prevalent as the population of elderly increases, but Canadian researchers report that age alone does not account for the increased incidence of OA among women...

Consumer News: Postmenopausal Women With Breast Cancer Face Joint Issues
Breast cancer patients who are postmenopausal and are receiving endocrine treatment may be at increased risk of joint issues such as arthritis...

BioPharm Business: Tolerx Reports Collaboration Partner, Genentech, has Advanced a Modified Humanized Nondepleting Anti-CD4 Monoclonal Antibody Into Phase I Clinical Trial in RA Patients
The Tolerx and Genentech collaboration has moved a modified version of TRX1 (MTRX1011A), an anti-CD4 monoclonal antibody, into a phase I clinical trial that has begun enrolling RA patients..

Click here to remove your e-mail address from our mailing list. For questions and comments regarding this newsletter please contact .